Blog
RSS FeedPosted by Michael Wonder on 07 Jul 2020
Use of infliximab biosimilar in Medicare population is low but growing
7 July 2020 - Slow growth of use of biosimilar infliximab in a Medicare fee-for-service population suggests lingering hesitancy on the ...
Posted by Michael Wonder on 07 Jul 2020
Abandoning list prices in Medicaid drug reimbursement did not affect spending
7 July 2020 - State fee-for-service Medicaid programs have traditionally based payments to pharmacies for drugs on a percentage of the ...
Posted by Michael Wonder on 06 Jul 2020
CMS’s proposed Medicaid best price loophole for value based purchasing of drugs
6 July 2020 - For three decades, US pharmaceutical companies have agreed to sell their products to Medicaid programs at ...
Posted by Michael Wonder on 28 Jun 2020
NICE's evaluations of medicines authorized by EMA with conditional marketing authorization or under exceptional circumstances
25 June 2020 - Products which received conditional marketing authorisation or authorisation in exceptional circumstances by European Medicines Agency up to ...
Posted by Michael Wonder on 25 Jun 2020
Federal prosecutors allege Regeneron used a charity to pay kickbacks to Medicare patients
24 June 2020 - Federal officials on Wednesday alleged that Regeneron Pharmaceuticals donated tens of millions of dollars to a ...
Posted by Michael Wonder on 23 Jun 2020
MHRA extends access to Santhera's DMD drug via the EAMS
23 June 2020 - The UK’s Medicines and Healthcare products Regulatory Agency has renewed for a further year the Early ...
Posted by Michael Wonder on 22 Jun 2020
Trump Administration proposes Medicaid reforms to encourage innovative contracting models
22 June 2020 - On Wednesday, June 17, the Centers for Medicare and Medicaid Services proposed a series of reforms ...
Posted by Michael Wonder on 17 Jun 2020
A mad scramble to stock millions of malaria pills, likely for nothing
16 June 2020 - Before the F.D.A. withdrew its waiver to stockpile the drugs as coronavirus treatments, the Trump administration had ...
Posted by Michael Wonder on 27 May 2020
Statement from Lilly Chairman and CEO Dave Ricks on the new Medicare Part D senior savings model
26 May 2020 - President Donald J. Trump and Seema Verma, Administrator for the Centers for Medicare & Medicaid Services, today ...
Posted by Michael Wonder on 26 May 2020
President Trump announces lower out of pocket insulin costs for Medicare’s seniors
26 May 2020 - Across the nation, 88 Part D Sponsors applied to the Part D Senior Savings Model to offer ...
Posted by Michael Wonder on 24 May 2020
Trump Administration announces changes to Medicare Advantage and Part D to provide better coverage and increase access for Medicare beneficiaries
22 May 2020 - Final Rule continues to strengthen the popular private Medicare health and drug plans. ...
Posted by Michael Wonder on 02 Apr 2020
Seqirus announces positive CHMP Opinion for its adjuvanted quadrivalent influenza vaccine
31 March 2020 - Seqirus today announced that its adjuvanted quadrivalent influenza vaccine - launching as Fluad Tetra - has received ...
Posted by Michael Wonder on 24 Mar 2020
Eleven states now letting uninsured sign up for Obamacare
23 March 2020 - More coronavirus care will be covered in many states. Federal officials are considering similar action for the ...
Posted by Michael Wonder on 18 Mar 2020
COVID-19: an update from Dr. Brian O’Rourke, CADTH President and CEO
18 March 2020 - As our country deals with the COVID-19 situation, CADTH has implemented several initiatives to mitigate the ...
Posted by Michael Wonder on 14 Mar 2020
Insulin costs may be capped in a Medicare program
11 March 2020 - If drug companies and insurers agree to participate, the Trump administration proposes limiting insulin costs to $35 ...